Devel Load (with references)

Add to Default shortcuts

Primary tabs

array:34 [
  "id" => array:1 [
    0 => array:1 [
      "value" => "4355"
    ]
  ]
  "isin" => array:1 [
    0 => array:1 [
      "value" => "DE000LS9KB42"
    ]
  ]
  "wkn" => array:1 [
    0 => array:1 [
      "value" => "LS9KB4"
    ]
  ]
  "name" => array:1 [
    0 => array:1 [
      "value" => "1PHARMA"
    ]
  ]
  "short_description" => array:1 [
    0 => array:1 [
      "value" => "PharmaInvest"
    ]
  ]
  "long_description" => array:1 [
    0 => array:1 [
      "value" => """
        In diesem wikifolio sollen Pharmatitel weltweit gehandelt werden. Es soll dabei auf Aktien  zurückgegriffen werden. In diesem wikifolio können keine Hebelprdukte gehandelt werden. Zur Entscheidungsfindung soll die Fundamentalanalyse gewählt werden.\r\n
        Newstrading soll ebenso angewandt werden. Der Anlagehorizont soll langfristig ca. 5- ca. 10 Jahre sein.\r\n
        """
    ]
  ]
  "status" => array:1 [
    0 => array:1 [
      "value" => "Investable"
    ]
  ]
  "trader_name" => array:1 [
    0 => array:1 [
      "value" => "OptiETF"
    ]
  ]
  "symbol" => array:1 [
    0 => array:1 [
      "value" => "WF01PHARMA"
    ]
  ]
  "creation_date" => array:1 [
    0 => array:1 [
      "value" => "1473167336"
    ]
  ]
  "issuing_date" => array:1 [
    0 => array:1 [
      "value" => "1478669605"
    ]
  ]
  "daily_free_relative" => array:1 [
    0 => array:1 [
      "value" => "0.95"
    ]
  ]
  "performance_free_relative" => array:1 [
    0 => array:1 [
      "value" => "10"
    ]
  ]
  "cash" => array:1 [
    0 => array:1 [
      "value" => "7.15696"
    ]
  ]
  "url" => array:1 [
    0 => array:1 [
      "value" => "https://www.wikifolio.com/de/ch/w/wf01pharma"
    ]
  ]
  "href" => array:1 [
    0 => array:1 [
      "value" => "https://api.wikifolio.com/api/v1/wikifolios/de000ls9kb42"
    ]
  ]
  "wikifolio_tags" => array:1 [
    0 => array:1 [
      "value" => "a:12:{i:0;a:3:{s:4:"Name";s:6:"akteur";s:16:"ShortDescription";s:13:"Aktien Europa";s:8:"TagGroup";s:15:"Anlageuniversum";}i:1;a:3:{s:4:"Name";s:11:"fundamental";s:16:"ShortDescription";s:20:"Fundamentale Analyse";s:8:"TagGroup";s:20:"Entscheidungsfindung";}i:2;a:3:{s:4:"Name";s:5:"aktde";s:16:"ShortDescription";s:18:"Aktien Deutschland";s:8:"TagGroup";s:15:"Anlageuniversum";}i:3;a:3:{s:4:"Name";s:8:"low-beta";s:16:"ShortDescription";s:8:"Low Beta";s:8:"TagGroup";s:14:"AlphaBetaGroup";}i:4;a:3:{s:4:"Name";s:8:"sonstige";s:16:"ShortDescription";s:16:"Sonstige Analyse";s:8:"TagGroup";s:20:"Entscheidungsfindung";}i:5;a:3:{s:4:"Name";s:6:"aktint";s:16:"ShortDescription";s:20:"Aktien International";s:8:"TagGroup";s:15:"Anlageuniversum";}i:6;a:3:{s:4:"Name";s:6:"akthot";s:16:"ShortDescription";s:17:"Aktien Hot Stocks";s:8:"TagGroup";s:15:"Anlageuniversum";}i:7;a:3:{s:4:"Name";s:11:"alpha-light";s:16:"ShortDescription";s:11:"Alpha Light";s:8:"TagGroup";s:14:"AlphaBetaGroup";}i:8;a:3:{s:4:"Name";s:8:"guter-ko";s:16:"ShortDescription";s:18:"Guter Kommunikator";s:8:"TagGroup";s:18:"Qualitätsmerkmale";}i:9;a:3:{s:4:"Name";s:6:"aktusa";s:16:"ShortDescription";s:10:"Aktien USA";s:8:"TagGroup";s:15:"Anlageuniversum";}i:10;a:3:{s:4:"Name";s:10:"regelm-akt";s:16:"ShortDescription";s:24:"Regelmäßige Aktivität";s:8:"TagGroup";s:18:"Qualitätsmerkmale";}i:11;a:3:{s:4:"Name";s:8:"techanal";s:16:"ShortDescription";s:18:"Technische Analyse";s:8:"TagGroup";s:20:"Entscheidungsfindung";}}"
    ]
  ]
  "rankings" => array:1 [
    0 => array:1 [
      "value" => "a:9:{i:0;a:4:{s:4:"Name";s:3:"aum";s:16:"ShortDescription";s:19:"Summe Investitionen";s:5:"Value";d:0;s:5:"Index";i:94244;}i:1;a:4:{s:4:"Name";s:8:"topwikis";s:16:"ShortDescription";s:23:"Top-wikifolio-Rangliste";s:5:"Value";d:4.474880805795;s:5:"Index";i:9357;}i:2;a:4:{s:4:"Name";s:6:"perf1m";s:16:"ShortDescription";s:19:"Performance 1 Monat";s:5:"Value";d:11.821011201;s:5:"Index";i:2389;}i:3;a:4:{s:4:"Name";s:7:"perf12m";s:16:"ShortDescription";s:18:"Performance 1 Jahr";s:5:"Value";d:50.562885557;s:5:"Index";i:3254;}i:4;a:4:{s:4:"Name";s:8:"perfever";s:16:"ShortDescription";s:23:"Performance seit Beginn";s:5:"Value";d:22.548316963328;s:5:"Index";i:32147;}i:5;a:4:{s:4:"Name";s:6:"perf3m";s:16:"ShortDescription";s:20:"Performance 3 Monate";s:5:"Value";d:9.806283612;s:5:"Index";i:13058;}i:6;a:4:{s:4:"Name";s:6:"perf6m";s:16:"ShortDescription";s:20:"Performance 6 Monate";s:5:"Value";d:16.131219802;s:5:"Index";i:8829;}i:7;a:4:{s:4:"Name";s:7:"maxdraw";s:16:"ShortDescription";s:26:"maximaler Verlust (bisher)";s:5:"Value";d:-72.5432639335;s:5:"Index";i:89917;}i:8;a:4:{s:4:"Name";s:11:"sharperatio";s:16:"ShortDescription";s:23:"Sharpe Ratio (365 Tage)";s:5:"Value";d:2.410885222355;s:5:"Index";i:1997;}}"
    ]
  ]
  "wikifolio_items" => array:1 [
    0 => array:1 [
      "value" => "a:20:{i:0;a:8:{s:4:"ISIN";s:12:"DK0062498333";s:3:"WKN";s:6:"A3EU6F";s:16:"ShortDescription";s:25:"NOVO-NORDISK AS B  DK 0,1";s:13:"AbsoluteValue";d:17505;s:13:"RelativeValue";d:2445.869734893922;s:12:"AbsoluteGain";d:224.75000000025;s:12:"RelativeGain";d:0.013006177572677089;s:8:"Quantity";d:450;}i:1;a:8:{s:4:"ISIN";s:12:"GB00BN7SWP63";s:3:"WKN";s:6:"A3DMB5";s:16:"ShortDescription";s:17:"GSK PLC  LS-,3125";s:13:"AbsoluteValue";d:2880.8;s:13:"RelativeValue";d:402.5170826782297;s:12:"AbsoluteGain";d:-68.69999999993;s:12:"RelativeGain";d:-0.023292083403943595;s:8:"Quantity";d:130;}i:2;a:8:{s:4:"ISIN";s:12:"CA4576377002";s:3:"WKN";s:6:"A40UCN";s:16:"ShortDescription";s:24:"INMED PHARMACEUT.INC.NEW";s:13:"AbsoluteValue";d:37.8;s:13:"RelativeValue";d:5.28156960748302;s:12:"AbsoluteGain";d:-3.9;s:12:"RelativeGain";d:-0.09352517985611511;s:8:"Quantity";d:30;}i:3;a:8:{s:4:"ISIN";s:12:"CH0012005267";s:3:"WKN";s:6:"904278";s:16:"ShortDescription";s:14:"NOVARTIS NAMEN";s:13:"AbsoluteValue";d:7036.7;s:13:"RelativeValue";d:983.1963189676128;s:12:"AbsoluteGain";d:-149.89999999997;s:12:"RelativeGain";d:-0.020858263991313086;s:8:"Quantity";d:55;}i:4;a:8:{s:4:"ISIN";s:12:"CH0432492467";s:3:"WKN";s:6:"A2PDXE";s:16:"ShortDescription";s:22:"ALCON AG  NAM. SF -,04";s:13:"AbsoluteValue";d:7689.6;s:13:"RelativeValue";d:1074.4221601508314;s:12:"AbsoluteGain";d:-311.89999999995;s:12:"RelativeGain";d:-0.03898019121414134;s:8:"Quantity";d:135;}i:5;a:8:{s:4:"ISIN";s:12:"AU000000CUV3";s:3:"WKN";s:6:"A0JEGY";s:16:"ShortDescription";s:24:"CLINUVEL PHARMACEUTICALS";s:13:"AbsoluteValue";d:1260.4;s:13:"RelativeValue";d:176.10820987491;s:12:"AbsoluteGain";d:78.4;s:12:"RelativeGain";d:0.06632825719120135;s:8:"Quantity";d:200;}i:6;a:8:{s:4:"ISIN";s:12:"BMG570071099";s:3:"WKN";s:6:"A116Z9";s:16:"ShortDescription";s:17:"LUYE PHARMA GROUP";s:13:"AbsoluteValue";d:2940;s:13:"RelativeValue";d:410.7887472486793;s:12:"AbsoluteGain";d:-715.999999988;s:12:"RelativeGain";d:-0.19584245076322487;s:8:"Quantity";d:14000;}i:7;a:8:{s:4:"ISIN";s:12:"BE0003766806";s:3:"WKN";s:6:"914998";s:16:"ShortDescription";s:24:"ION BEAM APPLICATIONS SA";s:13:"AbsoluteValue";d:19713.8;s:13:"RelativeValue";d:2754.4922467724537;s:12:"AbsoluteGain";d:971.60000000252;s:12:"RelativeGain";d:0.05184023220340465;s:8:"Quantity";d:1205;}i:8;a:8:{s:4:"ISIN";s:12:"DE000A11QVV0";s:3:"WKN";s:6:"A11QVV";s:16:"ShortDescription";s:25:"HEIDELBERG PHARMA AG O.N.";s:13:"AbsoluteValue";d:508;s:13:"RelativeValue";d:70.9798243545337;s:12:"AbsoluteGain";d:-22;s:12:"RelativeGain";d:-0.04150943396226415;s:8:"Quantity";d:200;}i:9;a:8:{s:4:"ISIN";s:12:"US68403P2039";s:3:"WKN";s:6:"A1CTNU";s:16:"ShortDescription";s:25:"ORAMED PHARMA.NEW DL-,001";s:13:"AbsoluteValue";d:5153.75;s:13:"RelativeValue";d:720.1028932424765;s:12:"AbsoluteGain";d:-705.99999999885;s:12:"RelativeGain";d:-0.12048295575732558;s:8:"Quantity";d:1550;}i:10;a:8:{s:4:"ISIN";s:12:"US7170811035";s:3:"WKN";s:6:"852009";s:16:"ShortDescription";s:18:"PFIZER INC. DL-,05";s:13:"AbsoluteValue";d:4411;s:13:"RelativeValue";d:616.322844936709;s:12:"AbsoluteGain";d:-208.5;s:12:"RelativeGain";d:-0.045134754843597795;s:8:"Quantity";d:200;}i:11;a:8:{s:4:"ISIN";s:12:"US87164F1057";s:3:"WKN";s:6:"A2AFL6";s:16:"ShortDescription";s:25:"SYNDAX PHARMACEU.DL-,0001";s:13:"AbsoluteValue";d:1627.5;s:13:"RelativeValue";d:227.4009136555189;s:12:"AbsoluteGain";d:-62;s:12:"RelativeGain";d:-0.03669724770642202;s:8:"Quantity";d:100;}i:12;a:8:{s:4:"ISIN";s:12:"US92556V1061";s:3:"WKN";s:6:"A2QAME";s:16:"ShortDescription";s:18:"VIATRIS INC.  O.N.";s:13:"AbsoluteValue";d:3971.4;s:13:"RelativeValue";d:554.9001465385732;s:12:"AbsoluteGain";d:-238.3999999998;s:12:"RelativeGain";d:-0.056629768635044736;s:8:"Quantity";d:300;}i:13;a:8:{s:4:"ISIN";s:12:"US92686J1060";s:3:"WKN";s:6:"A12GD6";s:16:"ShortDescription";s:25:"VIKING THERAPEUT.DL -,005";s:13:"AbsoluteValue";d:2096;s:13:"RelativeValue";d:292.86163749429653;s:12:"AbsoluteGain";d:7.00000000008;s:12:"RelativeGain";d:0.003350885591230382;s:8:"Quantity";d:80;}i:14;a:8:{s:4:"ISIN";s:12:"US4781601046";s:3:"WKN";s:6:"853260";s:16:"ShortDescription";s:17:"JOHNSON + JOHNSON";s:13:"AbsoluteValue";d:3553.92;s:13:"RelativeValue";d:496.56814442926066;s:12:"AbsoluteGain";d:-83.88;s:12:"RelativeGain";d:-0.02305789213260762;s:8:"Quantity";d:18;}i:15;a:8:{s:4:"ISIN";s:12:"SE0000202624";s:3:"WKN";s:6:"889714";s:16:"ShortDescription";s:9:"GETINGE B";s:13:"AbsoluteValue";d:19906.5;s:13:"RelativeValue";d:2781.417073845522;s:12:"AbsoluteGain";d:-190.4999999988;s:12:"RelativeGain";d:-0.009479026720346886;s:8:"Quantity";d:1150;}i:16;a:8:{s:4:"ISIN";s:12:"SE0000872095";s:3:"WKN";s:6:"A0LA5K";s:16:"ShortDescription";s:24:"SWEDISH ORPHAN BIOVITRUM";s:13:"AbsoluteValue";d:3994;s:13:"RelativeValue";d:558.0579103779677;s:12:"AbsoluteGain";d:-104;s:12:"RelativeGain";d:-0.02537823328452904;s:8:"Quantity";d:100;}i:17;a:8:{s:4:"ISIN";s:12:"US00287Y1091";s:3:"WKN";s:6:"A1J84E";s:16:"ShortDescription";s:25:"ABBVIE INC.        DL-,01";s:13:"AbsoluteValue";d:9475;s:13:"RelativeValue";d:1323.8855034630055;s:12:"AbsoluteGain";d:-147.5;s:12:"RelativeGain";d:-0.01532865679397246;s:8:"Quantity";d:50;}i:18;a:8:{s:4:"ISIN";s:12:"US1101221083";s:3:"WKN";s:6:"850501";s:16:"ShortDescription";s:25:"BRISTOL-MYERS SQUIBBDL-10";s:13:"AbsoluteValue";d:7068.75;s:13:"RelativeValue";d:987.6744752088781;s:12:"AbsoluteGain";d:-438.2499999999;s:12:"RelativeGain";d:-0.05837884641000477;s:8:"Quantity";d:150;}i:19;a:8:{s:4:"ISIN";s:12:"JP3160400002";s:3:"WKN";s:6:"855526";s:16:"ShortDescription";s:37:"EISAI CO. LTD. REGISTERED SHARES O.N.";s:13:"AbsoluteValue";d:1160.5;s:13:"RelativeValue";d:162.1497759122763;s:12:"AbsoluteGain";d:-39.949999999965;s:12:"RelativeGain";d:-0.03327918697152415;s:8:"Quantity";d:55;}}"
    ]
  ]
  "licence_switzerland" => array:1 [
    0 => array:1 [
      "value" => "1"
    ]
  ]
  "perf1m" => array:1 [
    0 => array:1 [
      "value" => "11.821"
    ]
  ]
  "perf12m" => array:1 [
    0 => array:1 [
      "value" => "50.5629"
    ]
  ]
  "perfever" => array:1 [
    0 => array:1 [
      "value" => "22.5483"
    ]
  ]
  "aum" => array:1 [
    0 => array:1 [
      "value" => "0"
    ]
  ]
  "topwikis" => array:1 [
    0 => array:1 [
      "value" => "9357"
    ]
  ]
  "created" => array:1 [
    0 => array:1 [
      "value" => "1649766873"
    ]
  ]
  "changed" => array:1 [
    0 => array:1 [
      "value" => "1781904086"
    ]
  ]
  "solid_valor" => array:1 [
    0 => array:1 [
      "value" => "34584027"
    ]
  ]
  "solid_bc" => array:1 [
    0 => array:1 [
      "value" => "BRN"
    ]
  ]
  "solid_bc_id" => array:1 [
    0 => array:1 [
      "value" => "5"
    ]
  ]
  "solid_cc" => array:1 [
    0 => array:1 [
      "value" => "CHF"
    ]
  ]
  "solid_cc_id" => array:1 [
    0 => array:1 [
      "value" => "1"
    ]
  ]
  "fullquote_link" => array:1 [
    0 => array:1 [
      "value" => "wikifolio/wf01pharma-lgszopen-34584027/brn/chf"
    ]
  ]
  "solid_changed" => array:1 [
    0 => array:1 [
      "value" => "1661283240"
    ]
  ]
]